Therapeutic Solutions International, Inc. (TSOI)

Market Cap	7.05K -99.8%
Revenue (ttm)	85.32K +1.9%
Net Income	-2.41M
EPS	-0.00
Shares Out	7.05B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	102,265
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0000 - 0.0004
Beta	0.50
RSI	97.63
Earnings Date	Mar 27, 2026

About TSOI

Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production. The company also produces n...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 3
• Stock Exchange: OTCMKTS
• Ticker Symbol: TSOI

Financial Performance

In 2023, TSOI's revenue was $98,994, a decrease of -52.12% compared to the previous year's $206,767. Losses were -$2.17 million, -43.11% less than in 2022.